 GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector Atishay Ltd empanelled as Business Associate with RailTel
Atishay Ltd empanelled as Business Associate with RailTel 
              A meeting of the Board of Directors of Venus Remedies Ltd is scheduled to be held on 18.03.2017 to allot 9,00,000 equity shares on conversion of fully convertible warrants to Promoters on preferential basis and any other item with the permission of chair.
The trading window shall be closed for the dealing in the securities of the company listed at your exchange with effect from March 15, 2017 to March 20, 2017 (both days inclusive) for all the Directors, Designated employees and other insiders in view of the aforesaid Board meeting.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.98.2 as compared to the previous close of Rs. 98.75. The total number of shares traded during the day was 10875 in over 175 trades.
The stock hit an intraday high of Rs. 99.3 and intraday low of 97. The net turnover during the day was Rs. 1068780.